We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-9.83%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$265M
AUM Growth
-$22M
(-7.6%)
Cap. Flow
+$5.67M
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
63.41%
Holding
63
New
13
Increased
11
Reduced
8
Closed
15
Top Buys
| 1 |
Teleflex
TFX
|
+$16.2M |
| 2 |
Smith & Nephew
SNN
|
+$14.5M |
| 3 |
VXRT
Vaxart
VXRT
|
+$12.3M |
| 4 |
Zimmer Biomet
ZBH
|
+$9.56M |
| 5 |
Abbott
ABT
|
+$9.49M |
Top Sells
| 1 |
Globus Medical
GMED
|
+$21.1M |
| 2 |
Cigna
CI
|
+$17M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
+$13.6M |
| 4 |
Medtronic
MDT
|
+$9.15M |
| 5 |
Embecta
EMBC
|
+$7.77M |
Sector Composition
| 1 | Healthcare | 96.64% |
| 2 | Consumer Staples | 3.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Labcorp
LH
$22.6B
| $50M | 18.87% |
245,902
+20,000
| +9% | +$4.07M |
|
|
2
Teleflex
TFX
$5.76B
| $23.4M | 8.81% |
111,078
+77,200
| +228% | +$16.2M |
|
|
3
Zimmer Biomet
ZBH
$17.6B
| $16.9M | 6.36% |
155,304
+81,125
| +109% | +$9.56M |
|
|
4
Smith & Nephew
SNN
$12.6B
| $14.4M | 5.42% |
+579,619
| New | +$14.5M |
|
5
Organon & Co
OGN
$3.55B
| $12.6M | 4.75% |
608,096
+129,073
| +27% | +$2.57M |
|
6
GSK
GSK
$103B
| $12M | 4.53% |
312,000
+48,555
| +18% | +$2.04M |
|
7
Corbus Pharmaceuticals
CRBP
$167M
| $10.2M | 3.84% |
+225,165
| New | +$9.47M |
|
|
VXRT
8
DELISTED
Vaxart
VXRT
| $9.85M | 3.72% |
+14,764,991
| New | +$12.3M |
|
9
Tyra Biosciences
TYRA
$1.96B
| $9.6M | 3.62% |
600,294
+64,553
| +12% | +$1.11M |
|
|
10
Abbott
ABT
$155B
| $9.3M | 3.51% |
+89,500
| New | +$9.49M |
|
|
11
Cigna
CI
$80.2B
| $8.85M | 3.34% |
26,786
-49,300
| -65% | -$17M |
|
12
Kenvue
KVUE
$36B
| $8.82M | 3.32% |
+485,000
| New | +$9.4M |
|
13
Disc Medicine
IRON
$2.87B
| $8.65M | 3.26% |
+192,000
| New | +$6.52M |
|
14
Erasca
ERAS
$6.06B
| $6.78M | 2.56% |
2,874,536
+447,352
| +18% | +$965K |
|
15
Biodesix
BDSX
$219M
| $6.65M | 2.51% |
+217,393
| New | +$6.21M |
|
|
ATXS
16
DELISTED
Astria Therapeutics
ATXS
| $4.64M | 1.75% |
510,267
+100,000
| +24% | +$976K |
|
17
ANI Pharmaceuticals
ANIP
$1.83B
| $4.57M | 1.72% |
71,740
-15,614
| -18% | -$1.01M |
|
18
Bausch + Lomb
BLCO
$5.69B
| $4.4M | 1.66% |
+302,710
| New | +$4.55M |
|
19
PMV Pharmaceuticals
PMVP
$75.7M
| $4.39M | 1.65% |
+2,708,408
| New | +$4.88M |
|
20
Zymeworks
ZYME
$1.81B
| $4.18M | 1.58% |
+491,128
| New | +$4.37M |
|
21
BridgeBio Pharma
BBIO
$16.5B
| $3.17M | 1.2% |
125,174
-78,000
| -38% | -$2.13M |
|
22
Apogee Therapeutics
APGE
$10.1B
| $3.07M | 1.16% |
78,000
| – | – |
|
23
Context Therapeutics
CNTX
$57.2M
| $2.66M | 1% |
+1,328,352
| New | +$2.29M |
|
24
Modular Medical
MODD
$23.3M
| $2.43M | 0.92% |
51,312
| – | – |
|
25
Stoke Therapeutics
STOK
$1.81B
| $2.37M | 0.89% |
175,301
-50,195
| -22% | -$678K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA